CTL Medical Corporation partners with G-21: 3 takeaways

Dallas-based CTL Medical signed a partnership agreement with G-21 to market G-21’s bone cement, kyphoplasty and vertebroplasty technology.

Advertisement

Here are three takeaways:

 

1. Each of the cement kits comes in the form of a two component system composed of a liquid and powder. The kits offer providers safety assurance and control of mechanical properties during surgery.

 

2. CTL Medical President and CEO Daniel Chon said, “We intend to begin immediate distribution of the full line of acrylic-based bone cements for widespread procedures necessary for vertebrae consolidation and stabilization.”

 

3. G-21 is an Italian-based biomaterials company that develops long-term implantable medical devices using raw materials.

 

More articles on devices:
ECA Medical Instruments’ sterile-packed, disposable orthopedics kits see growing adoption: 4 key notes
Zimmer Biomet CEO David Dvorak exits after 10 years
DePuy Synthes releases single use kits for wrist fracture surgery: 5 key points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.